fda tirzepatide news No, the is not taking GLP-1 medications off the market — but the compounded “copycat” versions may be getting a lot harder to access. This is where patient safety, cost, and access all collide., The FDA has declared an

Individual drugs have become blockbusters: Ozempic/Wegovy and Mounjaro/Zepbound each reached over $510 billion in annual sales within two years of launch

Rotating through four designated sites systematically allows each area at least three weeks of healing between injections, preventing lipohypertrophy and progressive discomfort

Nanocapsule Penetration Technology : Derma Laser's unique 3-level penetration technology with tiny hydrogenated lecithin capsules instantly releases active ingredients into the deep layers of the stratum corneum

TD and AN assisted with the sample processing and experiments

Lee Rosebush is a PharmD, attorney, and chair of the Outsourcing Facility Association, a trade group for 503B compounding pharmacies

One pattern worth flagging directly: prescription denials appear consistently in publicly available feedback